Figures computed from official regulatory filings — .
Analysttarget 6.28 USD (-4%) · consensus 3/5 · 0 buy · 4 hold · 0 sell
Ownershipinsiders 3.11% · institutions 72.49% · short 8.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for LIFECORE BIOMEDICAL, INC. \DE\ only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
69 buys584 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Kiper Christopher Strack record | Award | n/a (No price was disclosed in the filing) | SEC |
| HOUDE LOVAS KATRINA | Award | n/a (No price was disclosed in the filing) | SEC |
| Aryeh Jasontrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Schechter Joshuatrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Korenberg Matthew E | Award | n/a (No price was disclosed in the filing) | SEC |
| Johnson Paul Harold | Award | n/a (No price was disclosed in the filing) | SEC |
| Antunes Humberto Calheiros | Award | n/a (No price was disclosed in the filing) | SEC |
| OBUS NELSONtrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Josephs Paul | Other | $184.7K | SEC |
| Salus Thomas D. | Other | $128.2K | SEC |
| Salus Thomas D. | Award | n/a (No price was disclosed in the filing) | SEC |
| Lake Ryan David | Other | $176.8K | SEC |
| Legion Partners Holdings, LLCtrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Aryeh Jasontrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| HOUDE LOVAS KATRINA | Award | n/a (No price was disclosed in the filing) | SEC |
| Schechter Joshuatrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Johnson Paul Harold | Award | n/a (No price was disclosed in the filing) | SEC |
| Antunes Humberto Calheiros | Award | n/a (No price was disclosed in the filing) | SEC |
| Korenberg Matthew E | Award | n/a (No price was disclosed in the filing) | SEC |
| OBUS NELSONtrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Salus Thomas D. | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Josephs Paul | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Salus Thomas D. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Lake Ryan David | Other | $268.7K | SEC |
| Salus Thomas D. | Other | $90.3K | SEC |